Blood test can help clinicians better identify brain injury severity in patients
Researchers are developing blood-based biomarker tests to more accurately identify the severity of traumatic brain injuries in emergency settings. This diagnostic tool aims to improve patient outcomes by ensuring those with serious injuries receive timely and appropriate care.
Why it matters
Traumatic brain injuries are a leading cause of long-term disability, and better diagnostic tools could significantly reduce mortality and morbidity rates.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Artem Podrez from Pexels Clinician-scientists hope to expand the use of blood-based biomarker tests for traumatic brain injury (TBI) to improve identification and escalation of care for patients whose diagnosis otherwise might be missed.
In a study published in the Journal of Neurosurgery , a multi-institutional research team led by University of Pittsburgh School of Medicine neurosurgery clinician-scientists reports clinical cutoffs for two brain-associated proteins detected in the blood after brain injury that may help better identify and triage patients with TBI.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in